Theator Selects Kavi Vyas as Its Commercial Chief

Medtech startup theator has selected its first Chief Commercial Offer, Kavi Vyas, as it enters a new phase of growth.

His role on the company’s leadership team places him at the tip of the spear as the company scales its surgical intelligence platform, which uses advanced AI and computer vision to give surgeons actionable insights to help them improve their performance.

Vyas is an experienced medtech executive who comes to the Theator from Viz.ai, where he served as Vice President of Marketing. Throughout his 15 year career, he has also work as the Global Head of Embolization at Penumbra and spent time in roles at Medtronic and CardioDx.

"We are thrilled to welcome Kavi to theator. He comes with an exceptionally impressive skillset based on extensive experience of AI applications in healthcare, which will be instrumental toward theator's growth," CEO Dr. Tamir Wolf said in a press release.

The appointment comes as theator looks to continue its year of growth including a $15 million Series A funding round in February 2021, and a collaboration with Mayo Clinic in July.

--

The Org is a professional community where transparent companies can show off their team to the world. Join your company here to add yourself to the org chart!